• Cy3 TSA Fluorescence System Kit: Practical Guide

  2026-08-24

  The Cy3 TSA Fluorescence System Kit converts weak immunostaining or hybridization signals into high-contrast fluorescence for fixed cells and tissues. This application-focused guide connects the assay to the p53-R280K/SREBP1/FASN breast cancer axis, with workflow parameters, controls, and troubleshooting advice for reproducible imaging.

• VE-821: ATR Signaling Meets Viral Epigenetics

  2026-08-24

  VE-821 is a selective ATR kinase inhibitor for separating checkpoint failure from DNA repair and cell-death outcomes. This article develops a practical assay framework that connects ATR–Chk1 biology with, but carefully distinguishes it from, NS1–DNMT1 regulation of human bocavirus RNA processing.

• Maraviroc: CCR5 Biology Beyond HIV Entry

  2026-08-23

  Maraviroc, also known as UK-427857, is more than a tool for HIV-1 entry inhibition. This article examines how CCR5-directed pharmacology can dissect extracellular-vesicle signaling in rheumatoid arthritis while improving assay design across HIV tropism studies and inflammation research.

• OLIG2 Synthetic mRNA Drives Rapid hiPSC-to-OL Differentiatio

  2026-08-22

  Xu and colleagues developed a transgene-free strategy for converting human induced pluripotent stem cells into oligodendrocyte progenitor cells using repeated delivery of modified OLIG2 messenger RNA carrying the S147A mutation. The six-day induction workflow generated NG2-positive progenitors at greater than 70% purity, and the cells subsequently matured into functional oligodendrocytes capable of promoting remyelination in vivo.

• CCG-1423 Workflow for RhoA Signaling Studies

  2026-08-22

  CCG-1423 is a transcriptional-pathway RhoA inhibitor for dissecting MRTF-A nuclear import, proliferation, invasion, and apoptosis. This workflow also shows how to interpret RhoA/ROCK signaling and tight-junction phenotypes without assuming that CCG-1423 directly blocks ROCK1 kinase activity.

• Otilonium Bromide in Cholinergic Assays

  2026-08-21

  Otilonium Bromide provides a practical antimuscarinic perturbation tool for separating acetylcholine-driven effects in smooth muscle and neuronal assays. This guide translates product specifications and a structure-based screening study into workable assay design, controls, and troubleshooting decisions without overstating antiviral relevance.

• Streptavidin-FITC for LNP Trafficking

  2026-08-20

  Streptavidin-FITC turns biotin labeling into a high-affinity fluorescence readout for studying lipid nanoparticle trafficking. This article explains how assay architecture, controls, and endosomal interpretation can reveal delivery failures that simple uptake measurements miss.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-20

  Pair direct Cy5 tracking with EGFP expression to separate cellular uptake from productive translation in gene-delivery experiments. This dual-readout reporter is especially useful for benchmarking electroporation, nanoparticles, and macrophage-oriented delivery workflows without relying on secondary mRNA detection.

• LEE011 Succinate: pH-Aware Assay Design

  2026-08-19

  Discover how LEE011 succinate, a selective CDK inhibitor, can be evaluated through pH-aware dissolution and cell-cycle experiments. This evidence-based guide connects biorelevant solubility behavior with more interpretable cancer research assays.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist

  2026-08-19

  G-15 is a selective G protein-coupled estrogen receptor antagonist for separating GPR30 signaling from classical estrogen receptor activity. This guide translates its calcium, PI3K/Akt, proliferation, and spinal pain-model applications into practical workflows with dose selection, controls, and troubleshooting advice.

• Cyanine 3 Tyramide in Sensitive Tissue Assays

  2026-08-18

  Cyanine 3 Tyramide combines orange-red fluorescence with enzyme-mediated deposition to strengthen weak molecular signals in tissue and cell workflows. Its strongest use cases are low-abundance transcript detection, comparative neuroanatomy, and carefully controlled multiplex assays where conventional labeling may lack sensitivity.

• Hoechst 33342/PI Double Staining Kit for RCC

  2026-08-18

  This dual-fluorescence workflow separates viable, apoptotic, and membrane-compromised RCC cells through chromatin morphology and PI uptake. It is especially useful for testing syringin–sunitinib combinations, comparing treatment time points, and troubleshooting apparent drug-response differences.

• Tobramycin Workflows for Gram-Negative Research

  2026-08-17

  Build reproducible susceptibility, inoculum-effect, and resistance assays with Tobramycin, a water-soluble aminoglycoside antibiotic and bacterial protein synthesis inhibitor. This guide translates a large comparative in vitro study into practical plate design, control selection, and troubleshooting decisions for modern microbiology research.

• PPM-18 Workflows for iNOS and NF-κB Research

  2026-08-17

  PPM-18 provides a practical way to connect NF-κB activation with downstream iNOS expression, nitrite accumulation, and inflammatory cytokine release. This workflow-focused guide shows how to prepare the compound, design macrophage assays, interpret sepsis-relevant endpoints, and troubleshoot common sources of variability.

• Anti Reverse Cap Analog for Synthetic mRNA

  2026-08-16

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, gives in vitro transcription workflows a directionally selective Cap 0 structure designed for stronger protein output. Its value is especially clear when repeated, transient expression is needed for cellular reprogramming, mRNA therapeutics research, or other high-expression assays.

8464 records 1/565 page Next 12345 下5页 Last page